{"id":7994,"date":"2025-10-30T23:03:00","date_gmt":"2025-10-30T23:03:00","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/10\/30\/readout-loud-podcast-bridgebio-moderna-vaccines-biotech-metsera\/"},"modified":"2025-10-30T23:03:00","modified_gmt":"2025-10-30T23:03:00","slug":"readout-loud-podcast-bridgebio-moderna-vaccines-biotech-metsera","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/10\/30\/readout-loud-podcast-bridgebio-moderna-vaccines-biotech-metsera\/","title":{"rendered":"BridgeBio\u2019s great week and Moderna\u2019s unraveling"},"content":{"rendered":"<p>    BridgeBio\u2019s great week and Moderna\u2019s unraveling<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>Has BridgeBio\u2019s business model worked? How are executives at Moderna dealing with the company\u2019s slump? And who will the hosts dress up as for Halloween?<\/p>\n<p>We discuss all that on this week\u2019s episode of the \u201cThe Readout LOUD,\u201d STAT\u2019s biotech podcast. We bring on BridgeBio CEO Neil Kumar to discuss the company\u2019s positive Phase 3 readouts and our colleague Jason Mast to discuss Moderna\u2019s struggles following its Covid-19 vaccine boom.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/10\/30\/readout-loud-podcast-bridgebio-moderna-vaccines-biotech-metsera\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen, Adam Feuerstein, and Allison DeAngelis<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/10\/30\/readout-loud-podcast-bridgebio-moderna-vaccines-biotech-metsera\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BridgeBio\u2019s great week and Moderna\u2019s unraveling Has BridgeBio\u2019s business model worked? How are executives at Moderna dealing with the company\u2019s slump? And who will the hosts dress up as for Halloween? We discuss all that on this week\u2019s episode of the \u201cThe Readout LOUD,\u201d STAT\u2019s biotech podcast. We bring on BridgeBio CEO Neil Kumar to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2563,2595,2265],"tags":[2150],"class_list":["post-7994","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-moderna","category-novo-nordisk","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7994"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=7994"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7994\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=7994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=7994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=7994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}